The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cohen, H. J., Harris, T., & Pieper, C. F. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01484-5 · Cited by 327
Research works printed but not linked: 37
- Anderson, 1991, A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study, Arch Intern Med, 151, 933, 10.1001/archinte.1991.00400050081016 · DOI · Paper page
- Cushman, 2004, Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology, Am J Med, 117, 19, 10.1016/j.amjmed.2004.01.018 · DOI · Paper page
- Silverstein, 1998, Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch Intern Med, 158, 585, 10.1001/archinte.158.6.585 · DOI · Paper page
- Spencer, 2006, A population-based study of the clinical epidemiology of venous thromboembolism, J Gen Intern Med, 21, 722, 10.1111/j.1525-1497.2006.00458.x · DOI · Paper page
- Spencer, 2009, Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study, J Thromb Thrombolysis, 28, 401, 10.1007/s11239-009-0378-3 · DOI
- Raskob, 2010, Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop, Am J Prev Med, 38, S502, 10.1016/j.amepre.2010.01.010 · DOI · Paper page
- Tagalakis, 2011, Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database, Pharmacoepidemiol Drug Saf, 20, 304, 10.1002/pds.2061 · DOI
- Chew, 2008, The incidence of venous thromboembolism among patients with primary lung cancer, J Thromb Haemost, 6, 601, 10.1111/j.1538-7836.2008.02908.x · DOI · Paper page
- Anderson, 2003, Risk factors for venous thromboembolism, Circulation, 107, I9, 10.1161/01.CIR.0000078469.07362.E6 · DOI · Paper page
- Oger, 2000, Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale, J Thromb Haemost, 83, 657, 10.1055/s-0037-1613887 · DOI · Paper page
- Naess, 2007, Incidence and mortality of venous thrombosis: a population-based study, J Thromb Haemost, 5, 692, 10.1111/j.1538-7836.2007.02450.x · DOI · Paper page
- Tagalakis, 2012, Men had a higher risk of recurrent venous thromboembolism than women: a large population study, Gend Med, 9, 33, 10.1016/j.genm.2011.12.002 · DOI
- Baglin, 2004, High risk of recurrent venous thromboembolism in men, J Thromb Haemost, 2, 2152, 10.1111/j.1538-7836.2004.01050.x · DOI
- Rumley, 2006, Effects of older age on fibrin D-dimer, C-reactive protein and other hemostatic and inflammatory variables in men aged 60-79 years, J Thromb Haemost, 4, 982, 10.1111/j.1538-7836.2006.01889.x · DOI
- Previtali, 2011, Risk factors for venous and arterial thrombosis, Blood Transfus, 9, 120
- Yildiz, 2007, Vascular smooth muscle and endothelial functions in aging, Ann N Y Acad Sci, 1100, 353, 10.1196/annals.1395.038 · DOI
- 1997, Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment, Br J Surg, 84, 1099
- McLeod, 2001, Subcutaneous heparin versus low molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial, Ann Surg, 233, 438, 10.1097/00000658-200103000-00020 · DOI
- Akl, 2011, Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer, Cochrane Database Syst Rev, CD009447
- Agnelli, 2009, Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study, Lancet Oncol, 10, 943, 10.1016/S1470-2045(09)70232-3 · DOI · Paper page
- Agnelli, 2012, Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer, N Engl J Med, 366, 601, 10.1056/NEJMoa1108898 · DOI · Paper page
- Reiss H, Pelzer U, Deutschinoff G, et al. A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): results of the CONKO-004 trial. J Clin Oncol. 2009 ASCO Annual Meeting Proceedings. 2009;27(June 20 Suppl):LBA4506. · doi:10.1200/jco.2009.27.18_suppl.lba4506
- Bergqvist, 2002, Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer, N Engl J Med, 346, 975, 10.1056/NEJMoa012385 · DOI · Paper page
- Rasmussen, 2006, Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study, J Thromb Haemost, 4, 2384, 10.1111/j.1538-7836.2006.02153.x · DOI · Paper page
- Heit, 1999, Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study, Arch Intern Med, 159, 445, 10.1001/archinte.159.5.445 · DOI · Paper page
- Kniffin, 1994, The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly, Arch Intern Med, 154, 861, 10.1001/archinte.1994.00420080053005 · doi:10.1001/archinte.1994.00420080053005 · Paper page
- Hansson, 1997, Deep vein thrombosis and pulmonary embolism in the general population. ‘The Study of Men Born in 1913’, Arch Intern Med, 157, 1665, 10.1001/archinte.1997.00440360079008 · DOI · Paper page
- Prandoni, 1996, The long-term clinical course of acute deep venous thrombosis, Ann Intern Med, 125, 1, 10.7326/0003-4819-125-1-199607010-00001 · DOI · Paper page
- Piccioli, 1996, Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry, Am Heart J, 132, 1010, 10.1016/S0002-8703(96)90014-9 · DOI
- Siddique, 1998, Trends in pulmonary embolism mortality in the US elderly population: 1984 through 1991, Am J Public Health, 88, 478, 10.2105/AJPH.88.3.478 · DOI
- Goldhaber, 1999, Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER), Lancet, 353, 1386, 10.1016/S0140-6736(98)07534-5 · DOI · Paper page
- Andresen, 2011, Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy, Thromb Res, 127, 540, 10.1016/j.thromres.2011.02.017 · DOI
- Sørensen, 2000, Prognosis of cancers associated with venous thromboembolism, N Engl J Med, 343, 1846, 10.1056/NEJM200012213432504 · DOI · Paper page
- Levy, 1999, Coding accuracy of hospital discharge data for elderly survivals of myocardial infarction, Can J Cardiol, 15, 1277
- Garbe, 1998, Selection of controls in database case-control studies: glucocorticoids and the risk of glaucoma, J Clin Epidemiol, 51, 129, 10.1016/S0895-4356(97)00263-1 · DOI
- Firoozi, 2007, Development and validation of database indexes of asthma severity and control, Thorax, 62, 581, 10.1136/thx.2006.061572 · DOI
- Levy, 1995, Rates of transcervical and pertrochanteric hip fractures in the Province of Quebec, Canada, 1981-1992, Am J Epidemiol, 142, 428, 10.1093/oxfordjournals.aje.a117651 · doi:10.1093/oxfordjournals.aje.a117651
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
Metadata
- Authors
- Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 126
- Issue
- 9
- Pages
- 832.e13-832.e21
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1970889259
- Cited by
- 463
- References
- 1
- FWCI
- 22.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Bayer
- Canada Foundation for Innovation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort. https://app.cochat.ai/papers/10.1016/j.amjmed.2013.02.024
- The paper
- Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S. (2013). Incidence of and Mortality from Venous Thromboembolism in a Real-world Population: The Q-VTE Study Cohort. The American Journal of Medicine. https://doi.org/10.1016/j.amjmed.2013.02.024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.